2021
DOI: 10.3390/genes12030387
|View full text |Cite
|
Sign up to set email alerts
|

Analysis of MCM Proteins’ Role as a Potential Target of Statins in Patients with Acute Type A Aortic Dissection through Bioinformatics

Abstract: Acute aortic dissection is one of the most severe vascular diseases. The molecular mechanisms of aortic expansion and dissection are unclear. Clinical studies have found that statins play a protective role in aortic dissection development and therapy; however, the mechanism of statins’ effects on the aorta is unknown. The Gene Expression Omnibus (GEO) dataset GSE52093, GSE2450and GSE8686 were analyzed, and genes expressed differentially between aortic dissection samples and normal samples were determined using… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(5 citation statements)
references
References 39 publications
0
5
0
Order By: Relevance
“…First, the study did not examine whether the relationship of GC with the molecules was direct or indirect; hence, future research is required. Second, in terms of potential therapeutic targets, MCM4, MCM2, and MCM10 play an important role in aortic dissection, and MCMs expression is inhibited by statin treatment [29]. Therefore, MCM4 inhibition acting as a tumor suppressor could become a new therapeutic target through drug repositioning.…”
Section: Discussion/conclusionmentioning
confidence: 99%
“…First, the study did not examine whether the relationship of GC with the molecules was direct or indirect; hence, future research is required. Second, in terms of potential therapeutic targets, MCM4, MCM2, and MCM10 play an important role in aortic dissection, and MCMs expression is inhibited by statin treatment [29]. Therefore, MCM4 inhibition acting as a tumor suppressor could become a new therapeutic target through drug repositioning.…”
Section: Discussion/conclusionmentioning
confidence: 99%
“…Statins also reverse the increase in minichromosome maintenance (MCM) proteins in aortic disease. 69 In our cohort, the levels of MCM2, MCM3, MCM4, and MCM5 were diminished in VSMCs from TAA patients with a BAV compared to those with a TAV. Thus, statin therapy may prove to be contraindicated for BAV-TAA patients.…”
Section: Clinical Perspectives For Bav Patientsmentioning
confidence: 48%
“…Statins have been reported to inhibit TAA and dissection through different mechanisms. , Statins can upregulate specific small G proteins that protect against phenotype switching and reduce DNA oxidative damage, potentially providing benefits for BAV-TAA patients. Statins also reverse the increase in minichromosome maintenance (MCM) proteins in aortic disease . In our cohort, the levels of MCM2, MCM3, MCM4, and MCM5 were diminished in VSMCs from TAA patients with a BAV compared to those with a TAV.…”
Section: Discussionmentioning
confidence: 67%
“…It follows that our future focus and effort in the field of AAD research will be integrated studies combining proteomics, metabolomics, and other histological concepts. We anticipate finding more drug-targeting protein families in the future thanks to multi-omics integration approaches, which will allow us to investigate the molecular targets and potential pharmacological action mechanisms on AAD ( 166 ). The future therapy pathway for AAD will also include a critical stage involving the screening of biomarkers for acute pharmacological inhibitors, which may also serve as a model for the construction of drug resistance profiles.…”
Section: Current Shortcomings and Future Prospectsmentioning
confidence: 99%